AAAAAA
Results: 26-37/37
B9209-005, AN AZIDO DERIVATIVE OF THE CHEMOSENSITIZER DEXNIGULDIPINE-HCL, PHOTOLABELS P-GLYCOPROTEIN
Authors:
BORCHERS C
ULRICH WR
KLEMM K
ISE W
GEKELER V
HAAS S
SCHODL A
CONRAD J
PRZYBYLSKI M
BOER R
Citation: C. Borchers et al., B9209-005, AN AZIDO DERIVATIVE OF THE CHEMOSENSITIZER DEXNIGULDIPINE-HCL, PHOTOLABELS P-GLYCOPROTEIN, Molecular pharmacology, 48(1), 1995, pp. 21-29
Authors:
DEKONING HJ
FRACHEBOUD J
BOER R
VERBEEK ALM
COLLETTE HJA
HENDRIKS JHCL
VANINEVELD BM
DEBRUYN AE
VANDERMAAS PJ
Citation: Hj. Dekoning et al., NATIONWIDE BREAST-CANCER SCREENING IN THE NETHERLANDS - SUPPORT FOR BREAST-CANCER MORTALITY REDUCTION, International journal of cancer, 60(6), 1995, pp. 777-780
Authors:
HOFMANN J
GEKELER V
ISE W
NOLLER A
MITTERDORFER J
HOFER S
UTZ I
GOTWALD M
BOER R
GLOSSMANN H
GRUNICKE HH
Citation: J. Hofmann et al., MECHANISM OF ACTION OF DEXNIGULDIPINE-HCL (B8509-035), A NEW POTENT MODULATOR OF MULTIDRUG-RESISTANCE, Biochemical pharmacology, 49(5), 1995, pp. 603-609
Authors:
GEKELER V
BOER R
ISE W
SANDERS KH
SCHACHTELE C
BECK J
Citation: V. Gekeler et al., THE SPECIFIC BISINDOLYLMALEIMIDE PKC-INHIBITOR GF 109203X EFFICIENTLYMODULATES MRP-ASSOCIATED MULTIPLE-DRUG RESISTANCE, Biochemical and biophysical research communications, 206(1), 1995, pp. 119-126
Authors:
BOER R
HAAS S
SCHODL A
Citation: R. Boer et al., INFLUENCE OF DEXNIGULDIPINE-HCL ON RHODAMINE-123 ACCUMULATION IN A MULTIDRUG-RESISTANT LEUKEMIA-CELL LINE - COMPARISON WITH OTHER CHEMOSENSITIZERS, European journal of cancer, 30A(8), 1994, pp. 1117-1123
Authors:
BOER R
HAAS S
SCHODL A
Citation: R. Boer et al., INFLUENCE OF DEXNIGULDIPINE-HCL ON RHODAMINE-123 ACCUMULATION IN A MULTIDRUG-RESISTANT LEUKEMIA-CELL LINE - COMPARISON WITH OTHER CHEMOSENSITIZERS (VOL 30A, PG 1117, 1994), European journal of cancer, 30A(12), 1994, pp. 1910-1910
Authors:
MALKHANDI J
FERRY DR
BOER R
GEKELER V
ISE W
KERR DJ
Citation: J. Malkhandi et al., DEXNIGULDIPINE-HCL IS A POTENT ALLOSTERIC INHIBITOR OF [H-3] VINBLASTINE BINDING TO P-GLYCOPROTEIN OF CCRF ADR 5000 CELLS, European journal of pharmacology. Molecular pharmacology section, 288(1), 1994, pp. 105-114
Authors:
BOER R
WARMERDAM P
DEKONING H
VANOORTMARSSEN G
Citation: R. Boer et al., EXTRA INCIDENCE CAUSED BY MAMMOGRAPHIC SCREENING, Lancet, 343(8903), 1994, pp. 979-979
Authors:
BEEMSTERBOER PMM
DEKONING HJ
WARMERDAM PG
BOER R
SWART E
DIERKS ML
ROBRA BP
Citation: Pmm. Beemsterboer et al., PREDICTION OF THE EFFECTS AND COSTS OF BREAST-CANCER SCREENING IN GERMANY, International journal of cancer, 58(5), 1994, pp. 623-628
Authors:
CARTER R
GLASZIOU P
VANOORTMARSSEN G
DEKONING H
STEVENSON C
SALKELD G
BOER R
Citation: R. Carter et al., COST-EFFECTIVENESS OF MAMMOGRAPHIC SCREENING IN AUSTRALIA, Australian journal of public health, 17(1), 1993, pp. 42-50
Authors:
VANINEVELD BM
VANOORTMARSSEN GJ
DEKONING HJ
BOER R
VANDERMAAS PJ
Citation: Bm. Vanineveld et al., HOW COST-EFFECTIVE IS BREAST-CANCER SCREENING IN DIFFERENT EC COUNTRIES, European journal of cancer, 29A(12), 1993, pp. 1663-1668
Authors:
BOER R
CAMPBELL LC
FLETCHER DJ
Citation: R. Boer et al., CHARACTERISTICS OF FROST IN A MAJOR WHEAT-GROWING REGION OF AUSTRALIA, Australian Journal of Agricultural Research, 44(8), 1993, pp. 1731-1743